Abstract
We present a successful treatment, with tigecycline monotherapy, of acute prostatitis caused by multidrug-resistant Escherichia coli harboring an NDM-1 carbapemenase along with a CMY-2 cephalosporinase and a TEM ESBL.
| Original language | English |
|---|---|
| Article number | ofz551 |
| Journal | Open Forum Infectious Diseases |
| Volume | 7 |
| Issue number | 1 |
| Early online date | 9 Jan 2020 |
| DOIs | |
| Publication status | Published - Jan 2020 |
Keywords
- CMY-2
- EFFICACY
- INFECTIONS
- NDM-1
- PHASE-3
- SAFETY
- TEM ESBL
- prostatitis
- tigecyclin